Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study

✍ Scribed by Y Goto; N Hotta; Y Shigeta; N Sakamoto; R Kikkawa

• Book ID: 116152511
• Publisher: Elsevier Science
• Year: 1995
• Tongue: English
• Weight: 811 KB
• Volume: 49
• Category: Article
• ISSN: 0753-3322
• DOI: 10.1016/0753-3322(96)82642-4